home / stock / rdgl / rdgl quote
Last: | $0.1757 |
---|---|
Change Percent: | -1.16% |
Open: | $0.17713 |
Close: | $0.1757 |
High: | $0.178 |
Low: | $0.1732 |
Volume: | 104,170 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.1757 | $0.17713 | $0.1757 | $0.178 | $0.1732 | 104,170 | 07-19-2024 |
$0.1751 | $0.1884 | $0.1751 | $0.1894 | $0.1701 | 906,613 | 07-18-2024 |
$0.1888 | $0.1751 | $0.1888 | $0.1888 | $0.1751 | 1,073,806 | 07-17-2024 |
$0.184 | $0.1879 | $0.184 | $0.1879 | $0.1751 | 548,951 | 07-16-2024 |
$0.18365 | $0.185 | $0.18365 | $0.19 | $0.1811 | 511,132 | 07-15-2024 |
$0.185 | $0.185 | $0.185 | $0.19 | $0.1811 | 285,482 | 07-12-2024 |
$0.185 | $0.1965 | $0.185 | $0.199 | $0.185 | 977,837 | 07-11-2024 |
$0.1896 | $0.1733 | $0.1896 | $0.19 | $0.169 | 1,600,071 | 07-10-2024 |
$0.1731 | $0.165 | $0.1731 | $0.175 | $0.1621 | 1,885,898 | 07-09-2024 |
$0.1825 | $0.199 | $0.1825 | $0.199 | $0.1765 | 766,415 | 07-08-2024 |
$0.1925 | $0.179 | $0.1925 | $0.199 | $0.175 | 1,131,428 | 07-05-2024 |
$0.1778 | $0.17 | $0.1778 | $0.179 | $0.166 | 705,669 | 07-04-2024 |
$0.1778 | $0.17 | $0.1778 | $0.179 | $0.166 | 705,669 | 07-03-2024 |
$0.17 | $0.166 | $0.17 | $0.175 | $0.1615 | 1,221,456 | 07-02-2024 |
$0.165 | $0.2072 | $0.165 | $0.2099 | $0.1609 | 4,407,141 | 07-01-2024 |
$0.2035 | $0.2265 | $0.2035 | $0.2322 | $0.18588 | 2,413,151 | 06-28-2024 |
$0.225 | $0.19 | $0.225 | $0.24 | $0.1845 | 1,931,201 | 06-27-2024 |
$0.19 | $0.236 | $0.19 | $0.236 | $0.1834 | 3,677,063 | 06-26-2024 |
$0.221775 | $0.25 | $0.221775 | $0.25 | $0.2146 | 2,115,040 | 06-25-2024 |
$0.2359 | $0.2451 | $0.2359 | $0.2451 | $0.22 | 2,296,023 | 06-24-2024 |
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- By Meg Flippin, Benzinga In what could prove to be a transformational development in cancer treatment, Vivos (OTCQB: RDGL), the maker of the Radiogel™ Precision Radionuclide Therapy, submitted an application to the U.S. Food and Drug Administration (FDA) to init...
Richland WA, June 28, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”). The filing was an amendment, addressing the FDA comments to our previous application (Q211938/S001). Today’...
Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4 2023 BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023 Nicox SA (NICXF) is expected to report $-0.07 for Q4 2023 ...